{"name":"Yongtao Sun, MD, PhD","slug":"yongtao-sun-md-phd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"cART(TDF/AZT+3TC+LPV/r)","genericName":"cART(TDF/AZT+3TC+LPV/r)","slug":"cart-tdf-azt-3tc-lpv-r","indication":"Treatment of HIV-1 infection in adults and children","status":"phase_3"}]}],"pipeline":[{"name":"cART(TDF/AZT+3TC+LPV/r)","genericName":"cART(TDF/AZT+3TC+LPV/r)","slug":"cart-tdf-azt-3tc-lpv-r","phase":"phase_3","mechanism":"cART(TDF/AZT+3TC+LPV/r) is a combination antiretroviral therapy that works by inhibiting the replication of HIV.","indications":["Treatment of HIV-1 infection in adults and children","Prevention of mother-to-child transmission of HIV"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}